This 2nd position paper of our 2023 Medical Series proposes 5 recommendations and several tools to develop High-Performance…
News
In this position paper – the first of our 2023 Medical Series – we provide insights and…
In this position paper we have selected and analyzed 5 key topics that are specific to the…
This new position paper supplements the 320-page report entitled “The French Pharma Market 2022 – 2027 – Strategic Implications for Pharma…
2016 – 2022 COMPLETE COLLECTION – Insights – Concepts – Methods – Tools – We have the pleasure…
For big pharma companies having a dynamic pipeline of innovative products, Established Brands represent an essential source…
In this study, commissioned by the Gemme (French association of generics manufacturers), Smart Pharma Consulting has assessed the…
In this new position paper « Digital Therapeutics – What Opportunities for Pharma Companies » which completes a Key Note published…
This new position paper will provide you with an analysis of the value created by digitalization at…
We have the pleasure to share with you this Keynote we presented at the 13th Smart Pharma…